Literature DB >> 19844755

Renal cell carcinoma: real-time contrast-enhanced ultrasound findings.

Zuo-Feng Xu1, Hui-Xiong Xu, Xiao-Yan Xie, Guang-Jian Liu, Yan-Ling Zheng, Jin-Yu Liang, Ming-De Lu.   

Abstract

OBJECTIVE: To investigate the findings of renal cell carcinomas (RCCs) on contrast-enhanced ultrasound (CEUS).
METHODS: CEUS features of 84 RCCs confirmed by pathologic examination in 81 patients were retrospectively analyzed. A contrast-specific mode and a sulfur hexafluoride-filled microbubble contrast agent were used for CEUS. The enhancement pattern, extent, and dynamic change in the cortical, corticomedullary, and late phases were evaluated.
RESULTS: On CEUS, the emergence of tumor enhancement was earlier in two nodules (2.4%), simultaneous in 71 (84.5%), and later in 11 (13.1%), in comparison with the adjacent renal cortex. Seventy-four RCC nodules (88.1%) showed hyper-enhancement (n = 2) or iso-enhancement (n = 72) during the cortical phase, and the remaining 10 (11.9%) showed hypo-enhancement. Twenty-three nodules (27.4%) showed homogeneous enhancement and 61 (72.6%) inhomogeneous enhancement. In the corticomedullary phase, the nodules showed hypo-enhancement in 68 (81.0%) and iso-enhancement in 16 (19.0%). In the late phase, all RCCs showed the same enhancement pattern as that shown in the corticomedullary phase. Seventy-two (85.7%) nodules showed a clear perilesional rim-like enhancement in late phase.
CONCLUSIONS: Hyper- or iso-enhancement during the cortical phase, subsequent washout in late phase, inhomogeneous enhancement, and perilesional rim-like enhancement are clues for RCCs, which might be useful for characterization of RCCs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19844755     DOI: 10.1007/s00261-009-9583-y

Source DB:  PubMed          Journal:  Abdom Imaging        ISSN: 0942-8925


  23 in total

1.  Contrast-enhanced ultrasound: The evolving applications.

Authors:  Hui-Xiong Xu
Journal:  World J Radiol       Date:  2009-12-31

Review 2.  Management of incidental renal masses: Time to consider contrast-enhanced ultrasonography.

Authors:  Francesca Di Vece; Paola Tombesi; Francesca Ermili; Sergio Sartori
Journal:  Ultrasound       Date:  2016-01-14

3.  Era of diagnostic and interventional ultrasound.

Authors:  Hui-Xiong Xu
Journal:  World J Radiol       Date:  2011-05-28

Review 4.  The current role of contrast-enhanced ultrasound (CEUS) imaging in the evaluation of renal pathology.

Authors:  Salvatore Siracusano; Michele Bertolotto; Stefano Ciciliato; Massimo Valentino; Giovanni Liguori; Francesco Visalli
Journal:  World J Urol       Date:  2011-05-21       Impact factor: 4.226

5.  Acoustic radiation force impulse elastography in differentiating renal solid masses: a preliminary experience.

Authors:  Le-Hang Guo; Bo-Ji Liu; Hui-Xiong Xu; Chang Liu; Li-Ping Sun; Yi-Feng Zhang; Jun-Mei Xu; Jian Wu; Xiao-Hong Xu
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

Review 6.  [Innovative ultrasound-based diagnosis of renal tumors].

Authors:  K F Stock; J Slotta-Huspenina; H Kübler; M Autenrieth
Journal:  Urologe A       Date:  2019-12       Impact factor: 0.639

7.  Contrast-enhanced ultrasound of the kidney: a single-institution experience.

Authors:  Sheng F Oon; Robert W Foley; Deirdre Quinn; David M Quinlan; Robert G Gibney
Journal:  Ir J Med Sci       Date:  2017-12-07       Impact factor: 1.568

8.  Hepatocellular carcinoma after ablation: the imaging follow-up scheme.

Authors:  Lin-Na Liu; Hui-Xiong Xu; Yi-Feng Zhang; Jun-Mei Xu
Journal:  World J Gastroenterol       Date:  2013-02-14       Impact factor: 5.742

9.  Diagnostic accuracy of contrast-enhanced ultrasound for renal cell carcinoma: a meta-analysis.

Authors:  Cong Wang; Chong Yu; Fang Yang; Guang Yang
Journal:  Tumour Biol       Date:  2014-07

10.  Automating tumor classification with pixel-by-pixel contrast-enhanced ultrasound perfusion kinetics.

Authors:  Casey N Ta; Yuko Kono; Christopher V Barback; Robert F Mattrey; Andrew C Kummel
Journal:  J Vac Sci Technol B Nanotechnol Microelectron       Date:  2012-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.